Dahlöf B - Search Results

1

Telomere length is associated with ACE I/D polymorphism in hypertensive patients with left ventricular hypertrophy.

Fyhrquist F, Eriksson A, Saijonmaa O, Nordestgaard BG, Kontula K, de Faire U, Ibsen H, Kjeldsen S, Os I, Dahlöf B. Fyhrquist F, et al. Among authors: dahlof b. J Renin Angiotensin Aldosterone Syst. 2013 Sep;14(3):227-34. doi: 10.1177/1470320312460292. Epub 2012 Oct 17. J Renin Angiotensin Aldosterone Syst. 2013. PMID: 23077078 Free article.

2

The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.

Dahlöf B, Devereux R, de Faire U, Fyhrquist F, Hedner T, Ibsen H, Julius S, Kjeldsen S, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H. Dahlöf B, et al. Am J Hypertens. 1997 Jul;10(7 Pt 1):705-13. Am J Hypertens. 1997. PMID: 9234823 Clinical Trial.

3

Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension.

Dahlöf B, Devereux RB, Julius S, Kjeldsen SE, Beevers G, de Faire U, Fyhrquist F, Hedner T, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H. Dahlöf B, et al. Hypertension. 1998 Dec;32(6):989-97. doi: 10.1161/01.hyp.32.6.989. Hypertension. 1998. PMID: 9856962 Clinical Trial.

4

Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population : the LIFE study.

Wachtell K, Bella JN, Liebson PR, Gerdts E, Dahlöf B, Aalto T, Roman MJ, Papademetriou V, Ibsen H, Rokkedal J, Devereux RB. Wachtell K, et al. Among authors: dahlof b. Hypertension. 2000 Jan;35(1 Pt 1):6-12. doi: 10.1161/01.hyp.35.1.6. Hypertension. 2000. PMID: 10642267

5

Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study.

Okin PM, Jern S, Devereux RB, Kjeldsen SE, Dahlöf B; LIFE Study Group. Okin PM, et al. Among authors: dahlof b. Hypertension. 2000 Jan;35(1 Pt 1):13-8. doi: 10.1161/01.hyp.35.1.13. Hypertension. 2000. PMID: 10642268

6

Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Losartan Intervention For Endpoint.

Wachtell K, Smith G, Gerdts E, Dahlöf B, Nieminen MS, Papademetriou V, Bella JN, Ibsen H, Rokkedal J, Devereux RB. Wachtell K, et al. Among authors: dahlof b. Am J Cardiol. 2000 Feb 15;85(4):466-72. doi: 10.1016/s0002-9149(99)00773-0. Am J Cardiol. 2000. PMID: 10728952 Clinical Trial.

7

Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint.

Kjeldsen SE, Dahlöf B, Devereux RB, Julius S, de Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H. Kjeldsen SE, et al. Among authors: dahlof b. Am J Hypertens. 2000 Aug;13(8):899-906. doi: 10.1016/s0895-7061(00)00280-6. Am J Hypertens. 2000. PMID: 10950398 Clinical Trial.

8

Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators.

Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Dahlöf B. Okin PM, et al. Among authors: dahlof b. Hypertension. 2000 Nov;36(5):766-73. doi: 10.1161/01.hyp.36.5.766. Hypertension. 2000. PMID: 11082141 Clinical Trial.

9

Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (The LIFE Study). Losartan Intervention For Endpoint.

Wachtell K, Rokkedal J, Bella JN, Aalto T, Dahlöf B, Smith G, Roman MJ, Ibsen H, Aurigemma GP, Devereux RB. Wachtell K, et al. Among authors: dahlof b. Am J Cardiol. 2001 Jan 1;87(1):54-60. doi: 10.1016/s0002-9149(00)01272-8. Am J Cardiol. 2001. PMID: 11137834

10

Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study.

Okin PM, Devereux RB, Jern S, Julius S, Kjeldsen SE, Dahlöf B. Okin PM, et al. Among authors: dahlof b. Am J Hypertens. 2001 Aug;14(8 Pt 1):775-82. doi: 10.1016/s0895-7061(01)01291-2. Am J Hypertens. 2001. PMID: 11497193 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

399 results

Search Page